ROCHESTER, Mich. , Dec. 22, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today issued an open letter from the CEO to shareholders detailing the completion of internal
Oncologists share the factors that influence treatment selection and persistence in ALK+ lung cancer, revealing how pharma manufacturers can better support patients and physicians ROCHESTER, Mich. , Dec. 15, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading
- COVID-19 Consumer Health Communications Campaign won silver in the “Mobile Digital Health Resources: Text Messaging” category - TelaRep Interactive EHR Communication received a merit award in the “Connected Digital Health: Clinical Decision Support Tools” category ROCHESTER, Mich. , Dec.
Attributes 257% Revenue Growth to Brand Acquisition and Product Adoption ROCHESTER, Mich. , Nov. 23, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced its
ROCHESTER, Mich. , Nov. 22, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that the management team will participate in the Piper Sandler 33rd Annual
Event to be held December 9, 2021, 1:00-4:30 PM ET ROCHESTER, Mich. , Nov. 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, in partnership with Reuters Events™ will
Revenue Up 53% to $16.1 million , closing on 11 enterprise contracts Brands adopting OptimizeRx solutions increases to 182 from 140 in the past 6 months Real-world evidence (“RWE”) continues to gain traction and build revenue generating momentum Cash flow positive from operations of $2.1 million
ROCHESTER, Mich. , Oct. 27, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Tuesday, November 9, 2021, at 4:30 p.m.
OptimizeRx’s presentation will begin at 11:20 A.M. (track 2) on November 11, 2021 ROCHESTER, Mich. , Oct. 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced
